Characterizing the genetic architecture of Parkinson’s disease in Latinos

Douglas Loesch, Andrea R. V. R. Horimoto, Karl Heilbron, Elif Irem Sarihan, Miguel Inca-Martinez, Emily Mason, Mario Cornejo-Olivas, Luis Torres, Pilar Mazzetti, Carlos Cosentino, Elison Sarapura-Castro, Andrea Rivera-Valdivia, Angel C. Medina, Elena Dieguez, Victor Raggio, Andres Lescano, Vitor Tumas, Vanderci Borges, Henrique B. Ferraz, Carlos R. Rieder, Artur Schumacher-Schuh, Bruno L. Santos-Lobato, Carlos Velez-Pardo, Marlene Jimenez-Del-Rio, Francisco Lopera, Sonia Moreno, Pedro Chana-Cuevas, William Fernandez, Gonzalo Arboleda, Humberto Arboleda, Carlos E. Arboleda-Bustos, Dora Yearout, Cyrus P. Zabetian, the 23andMe Research Team, Paul Cannon, Timothy A. Thornton, Timothy D. O’Connor, Ignacio F. Mata on behalf of the Latin American Research Consortium on the Genetics of Parkinson’s Disease (LARGE-PD)
doi: https://doi.org/10.1101/2020.11.09.20227124

Article Information

doi 
https://doi.org/10.1101/2020.11.09.20227124
History 
  • November 12, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Douglas Loesch1,2,3,
  2. Andrea R. V. R. Horimoto4,
  3. Karl Heilbron5,
  4. Elif Irem Sarihan6,
  5. Miguel Inca-Martinez6,
  6. Emily Mason6,
  7. Mario Cornejo-Olivas7,8,
  8. Luis Torres9,10,
  9. Pilar Mazzetti7,10,
  10. Carlos Cosentino9,10,
  11. Elison Sarapura-Castro7,
  12. Andrea Rivera-Valdivia7,
  13. Angel C. Medina11,
  14. Elena Dieguez12,
  15. Victor Raggio13,
  16. Andres Lescano12,
  17. Vitor Tumas14,
  18. Vanderci Borges15,
  19. Henrique B. Ferraz15,
  20. Carlos R. Rieder16,
  21. Artur Schumacher-Schuh17,18,
  22. Bruno L. Santos-Lobato19,
  23. Carlos Velez-Pardo20,
  24. Marlene Jimenez-Del-Rio20,
  25. Francisco Lopera20,
  26. Sonia Moreno20,
  27. Pedro Chana-Cuevas21,
  28. William Fernandez22,
  29. Gonzalo Arboleda22,
  30. Humberto Arboleda22,
  31. Carlos E. Arboleda-Bustos22,
  32. Dora Yearout23,24,
  33. Cyrus P. Zabetian23,24,
  34. the 23andMe Research Team5,
  35. Paul Cannon5,
  36. Timothy A. Thornton25,
  37. Timothy D. O’Connor1,2,3,
  38. Ignacio F. Mata23,24,^,6,* and
  39. on behalf of the Latin American Research Consortium on the Genetics of Parkinson’s Disease (LARGE-PD)
  1. 1Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA
  2. 2Program in Personalized and Genomic Medicine, University of Maryland School of Medicine, Baltimore, MD, USA
  3. 3Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA
  4. 4Department of Biostatistics, University of Washington, Seattle, WA, USA
  5. 523andMe, Inc., Sunnyvale, CA, USA
  6. 6Lerner Research Institute, Genomic Medicine, Cleveland Clinic, Cleveland, OH, USA
  7. 7Neurogenetics Research Center, Instituto Nacional de Ciencias Neurologicas, Lima, Peru
  8. 8Center for Global Health, Universidad Peruana Cayetano Heredia, Lima, Peru
  9. 9Movement Disorders Unit, Instituto Nacional de Ciencias Neurologicas, Lima, Peru
  10. 10School of Medicine, Universidad Nacional Mayor de San Marcos, Lima, Peru
  11. 11Universidad Nacional del Altiplano, Puno, Peru
  12. 12Neurology Institute, Universidad de la República, Montevideo, Uruguay
  13. 13Department of Genetics, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay
  14. 14Ribeirão Preto Medical School, Universidade de São Paulo, Ribeirão Preto, Brazil
  15. 15Movement Disorders Unit, Department of Neurology and Neurosurgery, Universidade Federal de São Paulo, São Paulo, Brazil
  16. 16Departamento de Neurologia, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil
  17. 17Serviço de Neurologia, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
  18. 18Departamento de Farmacologia, Universidade Federal do Rio Grande do Sul, Brazil
  19. 19Instituto de Ciências da Saúde, Universidade Federal do Pará, Belém, Brazil
  20. 20Neuroscience Research Group, Medical Research Institute, Faculty of Medicine, Universidad de Antioquia (UdeA), Medellín, Antioquia, Colombia
  21. 21CETRAM, Facultad de ciencias Medicas, Universidad de Santiago de Chile, Chile
  22. 22Neuroscience and Cell Death Research Groups, Medical School and Genetic Institute, Universidad Nacional de Colombia, Bogotá, Colombia
  23. 23Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA
  24. 24Department of Neurology, University of Washington, Seattle, WA, USA
  25. 25Department of Biostatistics, University of Washington, Seattle, WA, USA
  1. ↵*Corresponding author: Lerner Research Institute R4-006, Cleveland Clinic Foundation, 9500 Euclid Ave., Cleveland, OH, 44195, USA., E-mail addresses: matai{at}ccf.org
Back to top
Posted November 12, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Characterizing the genetic architecture of Parkinson’s disease in Latinos
Douglas Loesch, Andrea R. V. R. Horimoto, Karl Heilbron, Elif Irem Sarihan, Miguel Inca-Martinez, Emily Mason, Mario Cornejo-Olivas, Luis Torres, Pilar Mazzetti, Carlos Cosentino, Elison Sarapura-Castro, Andrea Rivera-Valdivia, Angel C. Medina, Elena Dieguez, Victor Raggio, Andres Lescano, Vitor Tumas, Vanderci Borges, Henrique B. Ferraz, Carlos R. Rieder, Artur Schumacher-Schuh, Bruno L. Santos-Lobato, Carlos Velez-Pardo, Marlene Jimenez-Del-Rio, Francisco Lopera, Sonia Moreno, Pedro Chana-Cuevas, William Fernandez, Gonzalo Arboleda, Humberto Arboleda, Carlos E. Arboleda-Bustos, Dora Yearout, Cyrus P. Zabetian, the 23andMe Research Team, Paul Cannon, Timothy A. Thornton, Timothy D. O’Connor, Ignacio F. Mata
medRxiv 2020.11.09.20227124; doi: https://doi.org/10.1101/2020.11.09.20227124
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area